Yuka Kiriyama
Fujita Health University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuka Kiriyama.
Diagnostic Cytopathology | 2009
Makoto Urano; Yuka Kiriyama; Yasunari Takakuwa; Makoto Kuroda
Tall cell variant (TCV) of papillary thyroid carcinoma is a rare tumor, which is usually associated with poor outcome, and pathologists often face the dilemma of proper diagnosis of TCV, not only by cytology but also histology. To allow surgeons to determine aggressiveness of the tumor before operation, it is important for pathologists to detect tall cell features correctly by fine‐needle aspiration cytology (FNAC). However, the current criteria and definition of TCV are still controversial and confounded by another problem, the differential diagnosis from poorly differentiated thyroid carcinoma (PDC).
Helicobacter | 2016
Takeshi Toyoda; Liang Shi; Shinji Takasu; Young-Man Cho; Yuka Kiriyama; Akiyoshi Nishikawa; Kumiko Ogawa; Masae Tatematsu; Tetsuya Tsukamoto
Spices have been used for thousands of years, and recent studies suggest that certain spices confer beneficial effects on gastric disorders. The purpose of this study was to evaluate possible chemopreventive effects of spice‐derived compounds on Helicobacter pylori (H. pylori)‐induced gastritis.
International Journal of Molecular Sciences | 2017
Tetsuya Tsukamoto; Mitsuru Nakagawa; Yuka Kiriyama; Takeshi Toyoda; Xueyuan Cao
Although its prevalence is declining, gastric cancer remains a significant public health issue. The bacterium Helicobacter pylori is known to colonize the human stomach and induce chronic atrophic gastritis, intestinal metaplasia, and gastric cancer. Results using a Mongolian gerbil model revealed that H. pylori infection increased the incidence of carcinogen-induced adenocarcinoma, whereas curative treatment of H. pylori significantly lowered cancer incidence. Furthermore, some epidemiological studies have shown that eradication of H. pylori reduces the development of metachronous cancer in humans. However, other reports have warned that human cases of atrophic metaplastic gastritis are already at risk for gastric cancer development, even after eradication of these bacteria. In this article, we discuss the effectiveness of H. pylori eradication and the morphological changes that occur in gastric dysplasia/cancer lesions. We further assess the control of gastric cancer using various chemopreventive agents.
BioMed Research International | 2017
Atsushi Teramoto; Tetsuya Tsukamoto; Yuka Kiriyama; Hiroshi Fujita
Lung cancer is a leading cause of death worldwide. Currently, in differential diagnosis of lung cancer, accurate classification of cancer types (adenocarcinoma, squamous cell carcinoma, and small cell carcinoma) is required. However, improving the accuracy and stability of diagnosis is challenging. In this study, we developed an automated classification scheme for lung cancers presented in microscopic images using a deep convolutional neural network (DCNN), which is a major deep learning technique. The DCNN used for classification consists of three convolutional layers, three pooling layers, and two fully connected layers. In evaluation experiments conducted, the DCNN was trained using our original database with a graphics processing unit. Microscopic images were first cropped and resampled to obtain images with resolution of 256 × 256 pixels and, to prevent overfitting, collected images were augmented via rotation, flipping, and filtering. The probabilities of three types of cancers were estimated using the developed scheme and its classification accuracy was evaluated using threefold cross validation. In the results obtained, approximately 71% of the images were classified correctly, which is on par with the accuracy of cytotechnologists and pathologists. Thus, the developed scheme is useful for classification of lung cancers from microscopic images.
Clinical & Translational Oncology | 2017
Naomi Kobayashi; M. Hikichi; K. Ushimado; Atsushi Sugioka; Yuka Kiriyama; Makoto Kuroda; T. Utsumi
PurposeStage shift is considered a major reason for more favorable outcomes in patients with screen-detected breast cancer. However, even after adjusting for clinical stage, unresolved issues concerning the reasons for a survival benefit associated with screening programs remain. This study aims to evaluate differences in subtype distribution and outcomes among patients with screen-detected and symptomatic invasive breast cancer and assess whether variations in subtype distribution could explain differences in prognosis.MethodsSurvival analysis was performed to estimate the likelihood of distant recurrence and death in 1132 patients. Subtypes were defined as luminal A [estrogen receptor (ER)+ and/or progesterone receptor (PR)+, human epidermal growth factor receptor 2 (HER2)−, and Ki67 low], luminal B (HER2−) (ER+ and/or PR+, HER2−, and Ki67 high), luminal B (HER2+) (ER+ and/or PR+ and HER2+), HER2 overexpressing (ER−, PR−, and HER2+), and triple negative (ER−, PR−, and HER2−).ResultsScreen-detected cancers had favorable clinicopathological characteristics, such as smaller tumor size and a lower frequency of lymph node involvement. Women with screen-detected cancers had a survival advantage. Subtype distribution differed significantly among women with screen-detected and symptomatic cancer. Screen-detected cancers were more likely to be luminal A and less likely to be HER2 overexpressing or triple negative cancer compared with symptomatic cancers (luminal A 61.3 vs. 44.2%, HER2 overexpressing 4.0 vs. 8.0%, triple negative 8.0 vs. 15.9%). Node status, mode of detection, and subtype were independent prognostic factors in the multivariate analysis.ConclusionsDifferences in subtype distribution between screen-detected and symptomatic cancer could partially explain differences in outcomes.
Diagnostic Pathology | 2016
Yuka Kiriyama; Tetsuya Tsukamoto; Yoshikazu Mizoguchi; Shin Ishihara; Akihiko Horiguchi; Takamasa Tokoro; Y. Kato; Atsushi Sugioka; Makoto Kuroda
BackgroundPerivascular epithelioid-cell tumor (PEComa) is a group of rare mesenchymal neoplasms that express myomelanocytic-cell markers and exhibit a wide variety of histopathological features. Although heterotopic pancreas has been reported to occur in the gastrointestinal tract, intrahepatic heterotopic pancreas has been reported only rarely.Case presentationWe present a case of intrahepatic PEComa that showed a strong regional correlation with the presence of heterotopic pancreas. An intrahepatic tumor and biliary dilatation was incidentally discovered during a diagnostic evaluation to investigate low-back pain in a 47-year-old Japanese male. Cholangiocarcinoma was suspected and a left hemihepatectomy performed. Histological examination revealed a 3 × 3.8-mm tumor in the neighboring B2 bile duct. Histological and immunohistochemical investigations revealed the presence of a PEComa and pancreatic acini within the tumor mass. PEComa in the hepatobiliary and pancreatic regions are extremely rare. The presence of heterotopic pancreas is also relatively uncommon.ConclusionThe strong regional association of these 2 lesions raises the possibility of a PEComa originating from heterotopic pancreas or from an irritable response caused by heterotopic pancreas.
BMC Medical Genetics | 2015
Jun Miyazaki; Mayuko Ito; Haruki Nishizawa; Takema Kato; Yukito Minami; Hidehito Inagaki; Tamae Ohye; Masafumi Miyata; Hiroko Boda; Yuka Kiriyama; Makoto Kuroda; Takao Sekiya; Hiroki Kurahashi; Takuma Fujii
BackgroundIn the present study, we report on a couple who underwent prenatal genetic diagnosis for autosomal recessive polycystic kidney disease (ARPKD).Case presentationThis healthy couple had previously had a healthy boy but had experienced two consecutive neonatal deaths due to respiratory distress resulting from pulmonary hypoplasia caused by oligohydramnios. The woman consulted our facility after she realized she was pregnant again. We promptly performed a carrier test for the PKHD1 gene by target exome sequencing of samples from the couple. A pathogenic mutation was identified only in the paternal allele (c.9008C>T, p.S3003F). The mutation was confirmed by Sanger sequencing of the DNA from formalin-fixed, paraffin-embedded, kidney tissue of the second neonate patient and was not found in the healthy sibling. We then performed haplotype analyses using microsatellite markers scattered throughout the PKHD1 gene. DNA from the amniocentesis was determined to belong to a carrier, and the couple decided to continue with the pregnancy, obtaining a healthy newborn. Subsequent detailed examination of the exome data suggested higher read depth at exons 45 and 46. Multiplex ligation-dependent probe amplification allowed identification of duplication of these two exons. This case suggests the potential usefulness of target exome sequencing in the prenatal diagnosis of the PKHD1 gene in ARPKD.ConclusionsThis is the first report of intragenic duplication in the PKHD1 gene in ARPKD.
Journal of Obstetrics and Gynaecology | 2018
Akiko Ohwaki; Haruki Nishizawa; Noriko Aida; Takema Kato; Asuka Kambayashi; Jun Miyazaki; Mayuko Ito; Makoto Urano; Yuka Kiriyama; Makoto Kuroda; Masahiro Nakayama; Shin-ichi Sonta; Kaoru Suzumori; Takao Sekiya; Hiroki Kurahashi; Takuma Fujii
Akiko Ohwaki, Haruki Nishizawa, Noriko Aida, Takema Kato, Asuka Kambayashi, Jun Miyazaki, Mayuko Ito, Makoto Urano, Yuka Kiriyama, Makoto Kuroda, Masahiro Nakayama, Shin-Ichi Sonta, Kaoru Suzumori, Takao Sekiya, Hiroki Kurahashi and Takuma Fujii Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Toyoake, Japan; Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan; Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan; Department of Pathology and Laboratory Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Japan; Fetal Life Science Center, Ltd, Nagoya, Japan
Internal Medicine | 2018
M. Hikichi; Yuka Kiriyama; Takanori Hayashi; K. Ushimado; Naomi Kobayashi; Makoto Urano; Makoto Kuroda; T. Utsumi
A 50-year-old woman with a large right breast mass was emergently hospitalized for generalized weakness and fatigue. A histological examination of tumor biopsy specimens revealed a phyllodes tumor (PT). She suddenly lost consciousness due to severe hypoglycemia. Non-islet cell tumor hypoglycemia (NICTH) due to the PT was suspected. The tumor was emergently resected. A histological examination revealed a borderline PT. The patient recovered from the hypoglycemic episode. High-molecular-weight insulin-like growth factor II was detected in serum that had been collected preoperatively and in the tumor tissue, but not in serum that had been collected postoperatively. We herein present a case of a borderline PT with NICTH.
Open Journal of Pathology | 2016
Yuka Kiriyama; Tomomitsu Tahara; Tomoyuki Shibata; Masaaki Okubo; Mitsuru Nakagawa; Asako Okabe; Naoki Ohmiya; Makoto Kuroda; Atsushi Sugioka; Masao Ichinose; Masae Tatematsu; Tetsuya Tsukamoto